-
Something wrong with this record ?
Gliadin peptides activate blood monocytes from patients with celiac disease
Cinová J., Palová-Jelínková L., Smythies L.E., Černá M., Pecharová B., Dvořák M., Frühauf P., Tlaskalová-Hogenová H., Smith P.D., Tučková L.
Language English Country United States
NLK
ProQuest Central
from 1997-01-01
Health & Medicine (ProQuest)
from 1997-01-01
Public Health Database (ProQuest)
from 1997-01-01
Springer Nature OA/Free Journals
from 1981-01-01
- MeSH
- Macrophage Activation immunology MeSH
- CD40 Antigens metabolism MeSH
- B7-1 Antigen metabolism MeSH
- B7-2 Antigen metabolism MeSH
- Antigens, CD metabolism MeSH
- Celiac Disease immunology metabolism MeSH
- Cytokines biosynthesis MeSH
- Financing, Organized MeSH
- Gliadin metabolism MeSH
- HLA-DQ Antigens metabolism MeSH
- Immunoglobulins metabolism MeSH
- Interleukin-8 biosynthesis MeSH
- Humans MeSH
- Membrane Glycoproteins metabolism MeSH
- Monocytes metabolism MeSH
- NF-kappa B metabolism MeSH
- Peptide Fragments MeSH
- Flow Cytometry MeSH
- Tumor Necrosis Factor-alpha biosynthesis MeSH
- Check Tag
- Humans MeSH
To elucidate the role of innate immune responses in celiac disease, we investigated the effect of gliadin on blood monocytes from patients with celiac disease. Gliadin induced substantial TNF-alpha and IL-8 production by monocytes from patients with active celiac disease, lower levels by monocytes from patients with inactive celiac disease, and even lower levels by monocytes from healthy donors. In healthy donor monocytes gliadin induced IL-8 from monocytes expressing HLA-DQ2 and increased monocyte expression of the costimulatory molecules CD80 and CD86, the dendritic cell marker CD83, and the activation marker CD40. Gliadin also increased DNA binding activity of NF-kappaB p50 and p65 subunits in monocytes from celiac patients, and NF-kappaB inhibitors reduced both DNA binding activity and cytokine production. Thus, gliadin activation of HLA-DQ2(+) monocytes leading to chemokine and proinflammatory cytokine production may contribute to the host innate immune response in celiac disease.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc07527068
- 003
- CZ-PrNML
- 005
- 20200212091348.0
- 008
- 090809s2007 xxu e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Cinová, Jana $7 xx0104130
- 245 10
- $a Gliadin peptides activate blood monocytes from patients with celiac disease / $c Cinová J., Palová-Jelínková L., Smythies L.E., Černá M., Pecharová B., Dvořák M., Frühauf P., Tlaskalová-Hogenová H., Smith P.D., Tučková L.
- 314 __
- $a Institute of Microbiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic
- 520 9_
- $a To elucidate the role of innate immune responses in celiac disease, we investigated the effect of gliadin on blood monocytes from patients with celiac disease. Gliadin induced substantial TNF-alpha and IL-8 production by monocytes from patients with active celiac disease, lower levels by monocytes from patients with inactive celiac disease, and even lower levels by monocytes from healthy donors. In healthy donor monocytes gliadin induced IL-8 from monocytes expressing HLA-DQ2 and increased monocyte expression of the costimulatory molecules CD80 and CD86, the dendritic cell marker CD83, and the activation marker CD40. Gliadin also increased DNA binding activity of NF-kappaB p50 and p65 subunits in monocytes from celiac patients, and NF-kappaB inhibitors reduced both DNA binding activity and cytokine production. Thus, gliadin activation of HLA-DQ2(+) monocytes leading to chemokine and proinflammatory cytokine production may contribute to the host innate immune response in celiac disease.
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a CD antigeny $x metabolismus $7 D015703
- 650 _2
- $a antigeny CD40 $x metabolismus $7 D019013
- 650 _2
- $a antigeny CD80 $x metabolismus $7 D018122
- 650 _2
- $a antigeny CD86 $x metabolismus $7 D051940
- 650 _2
- $a celiakie $x imunologie $x metabolismus $7 D002446
- 650 _2
- $a cytokiny $x biosyntéza $7 D016207
- 650 _2
- $a průtoková cytometrie $7 D005434
- 650 _2
- $a gliadin $x metabolismus $7 D005903
- 650 _2
- $a HLA-DQ antigeny $x metabolismus $7 D006683
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunoglobuliny $x metabolismus $7 D007136
- 650 _2
- $a interleukin-8 $x biosyntéza $7 D016209
- 650 _2
- $a aktivace makrofágů $x imunologie $7 D008262
- 650 _2
- $a membránové glykoproteiny $x metabolismus $7 D008562
- 650 _2
- $a monocyty $x metabolismus $7 D009000
- 650 _2
- $a NF-kappa B $x metabolismus $7 D016328
- 650 _2
- $a peptidové fragmenty $7 D010446
- 650 _2
- $a TNF-alfa $x biosyntéza $7 D014409
- 700 1_
- $a Palová, Lenka, $d 1976- $7 mzk2008434074
- 700 1_
- $a Smythies, L. E.
- 700 1_
- $a Černá, Marie, $d 1964- $7 mzk2004258459
- 700 1_
- $a Pecharová, Barbara $7 xx0127962
- 700 1_
- $a Dvořák, Miloš, $d 1942 říjen 26.- $7 xx0225476
- 700 1_
- $a Frühauf, Pavel, $d 1951- $7 jn20000400733
- 700 1_
- $a Tlaskalová, Helena, $d 1938- $7 jn20000402365
- 700 1_
- $a Smith, Phillip D.
- 700 1_
- $a Tučková, Ludmila, $d 1945-
- 773 0_
- $w MED00002589 $t Journal of clinical immunology $g Roč. 27, č. 2 (2007), s. 201-209 $x 0271-9142
- 910 __
- $a ABA008 $b x $y 7 $z 0
- 990 __
- $a 20090726182400 $b ABA008
- 991 __
- $a 20200212091743 $b ABA008
- 999 __
- $a ok $b bmc $g 671062 $s 530235
- BAS __
- $a 3
- BMC __
- $a 2007 $b 27 $c 2 $d 201-209 $i 0271-9142 $m Journal of clinical immunology $x MED00002589
- LZP __
- $a 2009-B3/vtme